European Respiratory Society Statement on Long COVID Follow-Up. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Respiratory Journal Année : 2022

European Respiratory Society Statement on Long COVID Follow-Up.

(1) , (2, 1) , (3) , (4, 5) , (6) , (7, 8) , (9) , (10, 11) , (12) , (13) , (14) , (15) , (16)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Résumé

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aimed to identify optimal strategies for follow-up care that may positively impact the patient's quality of life (QoL). A European Respiratory Society (ERS) Task Force convened and prioritised eight clinical questions. A targeted search of the literature defined the timeline of "long COVID" as 1-6\hspace0.25emmonths post-infection and identified clinical evidence in the follow-up of patients. Studies meeting the inclusion criteria report an association of characteristics of acute infection with persistent symptoms, thromboembolic events in the follow-up period, and evaluations of pulmonary physiology and imaging. Importantly, this statement reviews QoL consequences, symptom burden, disability and home care follow-up. Overall, the evidence for follow-up care for patients with long COVID is limited.

Dates et versions

hal-03749904 , version 1 (11-08-2022)

Identifiants

Citer

Katerina M. Antoniou, Eirini Vasarmidi, Anne-Marie Russell, Claire Andrejak, Bruno Crestani, et al.. European Respiratory Society Statement on Long COVID Follow-Up.. European Respiratory Journal, 2022, 60 (2), ⟨10.1183/13993003.02174-2021⟩. ⟨hal-03749904⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More